The New Normal Five years ago, COVID-19 was declared a global pandemic, marking the official onset of a healthcare crisis ...

The challenge is that these are medium throughput compared to traditional approaches and are therefore best suited to phases where ... predict these events in drug discovery.

Learn how drug absorption and predictive modeling drive advancements in pharmaceuticals and precision medicine.

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

Biotech company Valo Health and AI healthcare firm nference have entered into a multi-year partnership to leverage AI and patient data in drug discovery and development. The collaboration will ...

AI-driven drug discovery can analyse millions of chemical compounds in ... Of these drugs, three are undergoing Phase II clinical trials, including Aspen Neuroscience’s ANPD-001, which is currently in ...

Insilico Medicine, whose Hong Kong IPO application lapsed in 2024, is still considering going public in the city, said ...

A US clinical-stage biotechnology company has introduced the first bipedal humanoid robot in its AI-driven, fully automated ...

Fast Company's annual list of the World's Most Innovative Companies spotlights organizations across various industries that are driving meaningful change through groundbreaking ideas and ...

The European Medicines Agency and Belgium’s Federal Agency for Medicines and Health Products have approved a Phase 2 challenge study on EV25, an antiviral therapeutic from Eradivir. The approval ...

For more information on the Phase 1b clinical trial, visit: https://clinicaltrials.gov/study/NCT06732180 ...